Home/Lyterian Therapeutics/Aaron Gitler, Ph.D.
AG

Aaron Gitler, Ph.D.

Scientific Founder

Lyterian Therapeutics

Therapeutic Areas

Lyterian Therapeutics Pipeline

DrugIndicationPhase
UndisclosedNeuroscience & Rare Disease FocusDiscovery